CVS HEALTH CORPORATION (CVS) FY2024 Q3 P&L / Income Statement

CVS HEALTH CORPORATION (CVS) FY2024 Q3 P&L / Income Statement

Income statement for 2024-07-01 through 2024-09-30. View: Revenue categories. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenues

95,428,000,000 US dollars

Total operating costs

94,596,000,000 US dollars

Operating income

832,000,000 US dollars

Other income (expense), net (calculated)

negative 727,000,000 US dollars

Income before income tax provision

105,000,000 US dollars

Income tax provision

34,000,000 US dollars

Net income

71,000,000 US dollars

Products

59,674,000,000 US dollars

Services

4,279,000,000 US dollars

Premiums

30,925,000,000 US dollars

Net investment income

550,000,000 US dollars

Cost of products sold

52,948,000,000 US dollars

Health care costs

29,922,000,000 US dollars

Operating expenses

10,557,000,000 US dollars

Restructuring charges

1,169,000,000 US dollars

Loss on assets held for sale

0 US dollars

Chart connections

• Revenue minus operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Of which attributable to CVS HEALTH CORPORATION: $87.00 M; to noncontrolling interests: −$16.00 M.